-
62013TN0073
Case T-73/13: Action brought on 11 February 2013 — InterMune UK and Others v EMA
OJ C 114, 20.4.2013, p. 38–38 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62013TN0062
Case T-62/13: Action brought on 6 February 2013 — GOLAM v OHIM — Glaxo Group (METABIOMAX)
OJ C 86, 23.3.2013, p. 27–27 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012CN0597
Case C-597/12 P: Appeal brought on 19 December 2012 by Isdin, SA against the judgment of the General Court (Fourth Chamber) delivered on 9 October 2012 in Case T-366/11: Bial-Portela & C a , SA v Office for Harmonisation in the Internal Market (Trade Marks and Designs)
OJ C 86, 23.3.2013, p. 8–8 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62011CA0360
Case C-360/11: Judgment of the Court (Third Chamber) of 17 January 2013 — European Commission v Kingdom of Spain (Failure of a Member State to fulfil obligations — Value added tax — Directive 2006/112/EC — Application of a reduced rate — Articles 96 and 98(2) — Points 3 and 4 of Annex III — ‘Pharmaceutical products normally used for health care, prevention of illnesses and as treatment for medical and veterinary purposes’ — ‘Medical equipment, aids and other appliances normally intended to alleviate or treat disability, for the exclusive personal use of the disabled’ )
OJ C 63, 2.3.2013, p. 4–5 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012TN0504
Case T-504/12: Action brought on 19 November 2012 — Murnauer Markenvertrieb v OHIM (NOTFALL CREME)
OJ C 26, 26.1.2013, p. 63–63 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012TN0502
Case T-502/12: Action brought on 19 November 2012 — Ferring v OHIM — Tillotts Pharma (OCTASA)
OJ C 26, 26.1.2013, p. 62–62 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012TN0501
Case T-501/12: Action brought on 19 November 2012 — Farmaceutisk Laboratorium Ferring v OHIM — Tillotts Pharma (OCTASA)
OJ C 26, 26.1.2013, p. 61–61 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012TN0493
Case T-493/12: Action brought on 14 November 2012 — Sanofi v OHIM — GP Pharm (GEPRAL)
OJ C 26, 26.1.2013, p. 56–56 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62011CB0587
Case C-587/11 P: Order of the Court (Seventh Chamber) of 18 September 2012 — Omnicare Inc. v Office for Harmonisation in the Internal Market (Trade Marks and Designs), Astellas Pharma GmbH (Appeal — Community trade mark — Application for registration of the word sign ‘OMNICARE CLINICAL RESEARCH’ — Opposition — Decision of the Board of Appeal rejecting the application — Action — Judgment of the General Court dismissing that action — Withdrawal of the opposition — Appeal — No need to adjudicate)
OJ C 9, 12.1.2013, p. 24–24 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
62012CN0443
Case C-443/12: Reference for a preliminary ruling from High Court of Justice (Chancery Division) (United Kingdom) made on 3 October 2012 — Actavis Group PTC EHF, Actavis UK Ltd v Sanofi
OJ C 389, 15.12.2012, p. 5–5 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
